Progenika

Microgenics, Astute Medical, and Siemens were among the firms whose tests and/or systems were cleared by the FDA for marketing last month.

The company aims to wrap up field trials for the system by the end of this year and will seek European regulatory clearance thereafter.

The kit is designed to be used on the same platform as Grifols' other molecular typing platforms and can provide results within four hours of DNA extraction.